More about
Metastatic Pancreatic Adenocarcinoma
News
February 13, 2024
1 min read
Save
FDA approves Onivyde as first-line treatment for metastatic pancreatic cancer
The FDA approved irinotecan liposome as part of a first-line regimen for the treatment of metastatic pancreatic adenocarcinoma.